FUCA2 and TSTA3 expression in gastric cancer: candidate biomarkers of malignant transformation.

Michael Williames Leal QuirinoAmanda Pinheiro de Barros AlbuquerqueMaria de Fátima Deodato de SouzaAntônio Felix da Silva FilhoMário Rino MartinsMaira Galdino da Rocha PittaMichelly Cristiny PereiraMoacyr Jesus Barreto de Melo Rêgo

Published in: Folia histochemica et cytobiologica (2023)

Alterations of FUCA2 and TSAT3 immunoexpression could lay the basis for future studies using cell glycosylation as a biomarker for the planning of therapeutic strategy in primary gastric cancer.

Keyphrases

poor prognosis
single cell
cell therapy
current status
case control
bone marrow